Hybrid Interventions for Pulmonary Vein Stenosis: Leveraging Intraoperative Endovascular Adjuncts in Challenging Clinical Scenarios
World Journal for Pediatric and Congenital Heart Surgery · 2024
DOI: 10.1177/21501351241247503 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal for Pediatric and Congenital Heart Surgery, 2024. Verfasst von Alyssa B Kalustian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Congenital Heart Surgery, Texas Children's Hospital, Houston, TX, USA. Hauptthemen laut MEDLINE: Stenosis, Pulmonary Vein, Pulmonary Veins, Stents, Angioplasty, Balloon. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Pediatric pulmonary vein stenosis (PVS) is often progressive and treatment-refractory, requiring multiple interventions. Hybrid pulmonary vein interventions (HPVIs), involving intraoperative balloon angioplasty or stent placement, leverage surgical access and customization to optimize patency while facilitating future transcatheter procedures. We review our experience with HPVI and explore potential applications of this collaborative approach.
Methods
Retrospective chart review of all HPVI cases between 2009 to 2023.
Results
Ten patients with primary (n = 5) or post-repair (n = 5) PVS underwent HPVI at median age of 12.7 months (range 6.6 months-9.5 years). Concurrent surgical PVS repair was performed in 7/10 cases. Hybrid pulmonary vein intervention was performed on 17 veins, 13 (76%) with prior surgical or transcatheter intervention(s). One patient underwent intraoperative balloon angioplasty of an existing stent. In total, 18 stents (9 bare metal [5-10 mm diameter], 9 drug eluting [3.5-5 mm diameter]) were placed in 16 veins. At first angiography (median 48 days [range 7 days-2.8 years] postoperatively), 8 of 16 (50%) HPVI-stented veins developed in-stent stenosis. Two patients died from progressive PVS early in the study, one prior to planned reintervention. Median time to first pulmonary vein reintervention was 86 days (10 days-2.8 years; 8/10 patients, 13/17 veins). At median survivor follow-up of 2.2 years (2.3 months-13.1 years), 1 of 11 surviving HPVI veins were completely occluded.
Conclusions
Hybrid pulmonary vein intervention represents a viable adjunct to existing PVS therapies, with promising flexibility to address limitations of surgical and transcatheter modalities. Reintervention is anticipated, necessitating evaluation of long-term benefits and durability as utilization increases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Congenital Heart Surgery, Texas Children's Hospital, Houston, TX, USA.
- Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
- Division of Pediatric Cardiology, Texas Children's Hospital, Houston, TX, USA.
- Division of Pediatric Cardiology, Baylor College of Medicine, Houston, TX, USA.
ORCID-Profile: Alyssa B Kalustian
Zitieren
APA
Kalustian, A. B., Brlecic, P. E., Gowda, S. T., Stapleton, G. E., Khan, A., Eilers, L. F., Birla, R., Imamura, M., Qureshi, A. M., Caldarone, C. A., & Bansal, M. (2024). Hybrid Interventions for Pulmonary Vein Stenosis: Leveraging Intraoperative Endovascular Adjuncts in Challenging Clinical Scenarios. World Journal for Pediatric and Congenital Heart Surgery. https://doi.org/10.1177/21501351241247503
Vancouver
Kalustian AB, Brlecic PE, Gowda ST, Stapleton GE, Khan A, Eilers LF, et al. Hybrid Interventions for Pulmonary Vein Stenosis: Leveraging Intraoperative Endovascular Adjuncts in Challenging Clinical Scenarios. World Journal for Pediatric and Congenital Heart Surgery. 2024. doi:10.1177/21501351241247503
BibTeX
@article{Kalustian2024,
author = {Kalustian, Alyssa B and Brlecic, Paige E and Gowda, Srinath T and Stapleton, Gary E and Khan, Asra and Eilers, Lindsay F and Birla, Ravi and Imamura, Michiaki and Qureshi, Athar M and Caldarone, Christopher A and Bansal, Manish},
title = {Hybrid Interventions for Pulmonary Vein Stenosis: Leveraging Intraoperative Endovascular Adjuncts in Challenging Clinical Scenarios},
journal = {World Journal for Pediatric and Congenital Heart Surgery},
year = {2024},
doi = {10.1177/21501351241247503}
}
EUVIMED